First Western Trust Bank Has $6.98 Million Stock Holdings in Danaher Co. (NYSE:DHR)

First Western Trust Bank lessened its stake in Danaher Co. (NYSE:DHR - Free Report) by 9.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,103 shares of the conglomerate's stock after selling 2,507 shares during the period. Danaher comprises approximately 0.3% of First Western Trust Bank's investment portfolio, making the stock its 25th largest holding. First Western Trust Bank's holdings in Danaher were worth $6,979,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Strengthening Families & Communities LLC lifted its position in shares of Danaher by 9.1% during the 3rd quarter. Strengthening Families & Communities LLC now owns 3,913 shares of the conglomerate's stock valued at $1,088,000 after buying an additional 326 shares in the last quarter. Quest Partners LLC purchased a new position in shares of Danaher during the 3rd quarter valued at approximately $1,941,000. Aljian Capital Management LLC purchased a new position in shares of Danaher during the 3rd quarter valued at approximately $652,000. Atlanta Consulting Group Advisors LLC purchased a new position in shares of Danaher during the 3rd quarter valued at approximately $267,000. Finally, Accredited Investors Inc. purchased a new position in shares of Danaher during the 3rd quarter valued at approximately $278,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Price Performance

Shares of NYSE:DHR traded down $0.54 on Monday, hitting $229.96. The company had a trading volume of 2,721,731 shares, compared to its average volume of 2,759,932. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a 52-week low of $207.63 and a 52-week high of $281.70. The business has a 50 day moving average of $262.20 and a 200 day moving average of $260.57. The company has a market cap of $166.09 billion, a PE ratio of 43.99, a PEG ratio of 4.24 and a beta of 0.85.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the business earned $2.02 earnings per share. The business's revenue was up 3.1% on a year-over-year basis. As a group, equities analysts anticipate that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.47%. Danaher's payout ratio is currently 20.61%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on DHR shares. Leerink Partners increased their target price on Danaher from $275.00 to $280.00 and gave the company an "outperform" rating in a research report on Wednesday, July 24th. Stephens reissued an "overweight" rating and issued a $315.00 price objective on shares of Danaher in a research note on Wednesday, October 23rd. The Goldman Sachs Group increased their price objective on Danaher from $225.00 to $250.00 and gave the company a "neutral" rating in a research note on Wednesday, July 24th. Robert W. Baird reduced their price objective on Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a research note on Wednesday, October 23rd. Finally, TD Cowen increased their price objective on Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a research note on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $287.16.

Insider Activity at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. This trade represents a 18.44 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 11.10% of the company's stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.